CORMEDIX INC. - COMMON STOCK

CorMedix Inc. Announces Executive Leadership Changes

04 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Regulatory Update

07 Sep 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

12 Aug 2021 16:01:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Second Quarter 2021 Financial Results and Provide a Corporate Update on August 12

28 Jul 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Completes Sale of $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

10 Jun 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate in Fireside Chat at the JMP Securities Life Sciences Conference

09 Jun 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the Jefferies Virtual Healthcare Conference

27 May 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

13 May 2021 16:01:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Appointment of Chief Commercial Officer

13 May 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report First Quarter 2021 Financial Results and Provide a Corporate Update on May 13

05 May 2021 08:00:02 By Nasdaq GlobeNewswire

CorMedix Inc. to Participate at the 7th Annual Truist Securities Life Sciences Summit

28 Apr 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Has Meeting With FDA on DefenCath Catheter Lock Solution NDA

14 Apr 2021 09:00:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference

07 Apr 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

30 Mar 2021 16:05:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results and Provide a Corporate Update on March 30

23 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Approved to Sell $1.3 Million of NOL Tax Benefits Through The New Jersey Economic Development Authority Program

15 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. Announces Contract Extension of Liz Masson-Hurlburt as Executive Vice President and Head of Clinical Operations

11 Mar 2021 08:30:00 By Nasdaq GlobeNewswire

CorMedix Inc. to Host Regulatory Update Conference Call

08 Mar 2021 17:00:00 By Nasdaq GlobeNewswire

CorMedix Receives Complete Response Letter From FDA for DefenCath™ Catheter Lock Solution

01 Mar 2021 08:30:00 By Nasdaq GlobeNewswire